TY  - GEN
AU  - Blakely,Collin M
AU  - Pazarentzos,Evangelos
AU  - Olivas,Victor
AU  - Asthana,Saurabh
AU  - Yan,Jenny Jiacheng
AU  - Tan,Irena
AU  - Hrustanovic,Gorjan
AU  - Chan,Elton
AU  - Lin,Luping
AU  - Neel,Dana S
AU  - Newton,William
AU  - Bobb,Kathryn L
AU  - Fouts,Timothy R
AU  - Meshulam,Jeffrey
AU  - Gubens,Matthew A
AU  - Jablons,David M
AU  - Johnson,Jeffrey R
AU  - Bandyopadhyay,Sourav
AU  - Krogan,Nevan J
AU  - Bivona,Trever G
TI  - NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer
SN  - 2211-1247
PY  - 2016///0104
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adenocarcinoma of Lung
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Apoptosis
KW  - drug effects
KW  - Cell Line, Tumor
KW  - Cell Survival
KW  - Cyclohexanones
KW  - Drug Resistance, Neoplasm
KW  - genetics
KW  - Epoxy Compounds
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - I-kappa B Kinase
KW  - Lung Neoplasms
KW  - Molecular Targeted Therapy
KW  - NF-kappa B
KW  - Nuclear Pore Complex Proteins
KW  - Proto-Oncogene Proteins c-akt
KW  - RNA-Binding Proteins
KW  - Signal Transduction
KW  - TNF Receptor-Associated Factor 2
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.celrep.2015.03.012
ER  -